Noritaka Kagaya

Noritaka Kagaya

Auto-generated profile, based on publicly available information

Noritaka Kagaya

National Institute of Advanced Industrial Science and Technology, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SBSoniya Bastola
Soniya Bastola
MPMarat S. Pavlyukov
Marat S. Pavlyukov
DYDaisuke Yamashita
Daisuke Yamashita
SGSadashib Ghosh
Sadashib Ghosh
HCHeejin Cho
Heejin Cho
INIchiro Nakano
Ichiro Nakano
Intratumor spatial heterogeneity facilitates therapeutic resistance in glioblastoma (GBM). Nonetheless, understanding of GBM heterogeneity is largely limited to the surgically resectable tumor core lesion while the seeds for recurrence reside in the unresectable tumor edge. In this study, stratification of GBM to core and edge demonstrates clinically relevant surgical sequelae. We establish regionally derived models of GBM edge and core that retain their spatial identity in a cell autonomous manner. Upon xenotransplantation, edge-derived cells show a higher capacity for infiltrative growth, while core cells demonstrate core lesions with greater therapy resistance. Investigation of intercellular signaling between these two tumor populations uncovers the paracrine crosstalk from tumor core that promotes malignancy and therapy resistance of edge cells. These phenotypic alterations are initiated by HDAC1 in GBM core cells which subsequently affect edge cells by secreting the soluble form of CD109 protein. Our data reveal the role of intracellular communication between regionally different populations of GBM cells in tumor recurrence.

11 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
KKKei Kudo
Kei Kudo
THTakuya Hashimoto
Takuya Hashimoto
JHJunko Hashimoto
Junko Hashimoto
IKIkuko Kozone
Ikuko Kozone
NKNoritaka Kagaya
Noritaka Kagaya
KSKazuo Shin-Ya
Kazuo Shin-Ya
One major bottleneck in natural product drug development is derivatization, which is pivotal for fine tuning lead compounds. A promising solution is modifying the biosynthetic machineries of middle molecules such as macrolides. Although intense studies have established various methodologies for protein engineering of type I modular polyketide synthase(s) (PKSs), the accurate targeting of desired regions in the PKS gene is still challenging due to the high sequence similarity between its modules. Here, we report an innovative technique that adapts in vitro Cas9 reaction and Gibson assembly to edit a target region of the type I modular PKS gene. Proof-of-concept experiments using rapamycin PKS as a template show that heterologous expression of edited biosynthetic gene clusters produced almost all the desired derivatives. Our results are consistent with the promiscuity of modular PKS and thus, our technique will provide a platform to generate rationally designed natural product derivatives for future drug development.

8 February 2021 in The Journal of Antibiotics
Verified
Journal Article
Closed access
PDF file
THTakuya Hashimoto
Takuya Hashimoto
JHJunko Hashimoto
Junko Hashimoto
NKNoritaka Kagaya
Noritaka Kagaya
TNTakehiro Nishimura
Takehiro Nishimura
HSHikaru Suenaga
Hikaru Suenaga
KSKazuo Shin-Ya
Kazuo Shin-Ya

15 October 2020 in The Journal of Antibiotics
Verified
Journal Article
Closed access
PDF file
RUReiko Ueoka
Reiko Ueoka
NSNaoya Shinzato
Naoya Shinzato
NKNoritaka Kagaya
Noritaka Kagaya
HSHikaru Suenaga
Hikaru Suenaga
KSKazuo Shin-Ya
Kazuo Shin-Ya